Exploring Innovations in Secondary Metabolites and Their Effects on Pain, Inflammation and Metabolic Syndrome

Abstract

Secondary metabolites, once considered non-essential by-products of plant and microbial metabolism, have emerged as potent bioactive molecules with tremendous therapeutic promise. Recent advances in biotechnology, omics technologies, and natural product chemistry have enabled the identification and engineering of these molecules at an accelerated pace, highlighting their potential to modulate complex disease mechanisms. This editorial discusses novel breakthroughs in secondary metabolites, focusing on their applications in pain modulation, anti-inflammation, and metabolic regulation. Through exemplary examples, we emphasize the translational potential of these natural products and underline the necessity of an interdisciplinary strategy to surmount current bottlenecks in clinical translation.